Brazil’s 2022–23 #vaccine policy didn’t adopt #PCV13 (3 more strains vs PCV10). Why? Priorities like #DomesticProduction, #Costs & #Surveillance outweighed clinical benefits.
📖More: www.sciencedirect.com/science/arti...
📰Digest: onehealthtrust.org/news-media/w...